| scholarly article | Q13442814 |
| P50 | author | David L Gally | Q61041315 |
| Nuria Carpena | Q82251999 | ||
| James P R Connolly | Q86357269 | ||
| Alejandro Huerta-Uribe | Q88970839 | ||
| Gillian R Douce | Q56453145 | ||
| Andrew J Roe | Q57162322 | ||
| Rudi Marquez | Q57248644 | ||
| Mikael Elofsson | Q59822145 | ||
| P2093 | author name string | Stephen Fitzgerald | |
| Olwyn Byron | |||
| Hanna Uvell | |||
| Nao Yamaguchi | |||
| Zoe R Marjenberg | |||
| P2860 | cites work | Transcription of the sulA gene and repression by LexA | Q70181052 |
| Angiogenesis inhibition by the maleimide-based small molecule GNX-686 | Q82362443 | ||
| Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections | Q24550740 | ||
| Directed molecular screening for RecA ATPase inhibitors | Q24684082 | ||
| Mechanism of homologous recombination from the RecA-ssDNA/dsDNA structures | Q27650665 | ||
| Inhibitors of RecA activity discovered by high-throughput screening: cell-permeable small molecules attenuate the SOS response in Escherichia coli | Q30479751 | ||
| Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome | Q33365488 | ||
| Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations | Q33374948 | ||
| Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks | Q33378926 | ||
| Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools | Q33475757 | ||
| Novel Inhibitors of E. coli RecA ATPase Activity | Q33637395 | ||
| A brief overview of Escherichia coli O157:H7 and its plasmid O157. | Q34097110 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells | Q34273832 | ||
| SOS response promotes horizontal dissemination of antibiotic resistance genes | Q34285480 | ||
| Shiga toxins | Q34298388 | ||
| Shiga toxin subtypes display dramatic differences in potency | Q34739913 | ||
| High-throughput screening for RecA inhibitors using a transcreener adenosine 5'-O-diphosphate assay | Q36029187 | ||
| Staphylococcal pathogenicity island DNA packaging system involving cos-site packaging and phage-encoded HNH endonucleases. | Q37725250 | ||
| Impact of recA on levofloxacin exposure-related resistance development | Q42421178 | ||
| Showdomycin as a versatile chemical tool for the detection of pathogenesis-associated enzymes in bacteria | Q43078335 | ||
| Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. | Q44838252 | ||
| Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides. | Q46073000 | ||
| Sedimentation equilibrium analysis of protein interactions with global implicit mass conservation constraints and systematic noise decomposition | Q47994334 | ||
| RecA Inhibitors Potentiate Antibiotic Activity and Block Evolution of Antibiotic Resistance | Q50868599 | ||
| Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials. | Q54372713 | ||
| Production of antioomycete compounds active against the phytopathogens Phytophthora sojae and Aphanomyces cochlioides by clavicipitoid entomopathogenic fungi. | Q54546386 | ||
| RecA protein self-assembly. II. Analytical equilibrium ultracentrifugation studies of the entropy-driven self-association of RecA. | Q54704794 | ||
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 1930 | |
| P577 | publication date | 2016-11-30 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Identification and Characterization of Novel Compounds Blocking Shiga Toxin Expression in Escherichia coli O157:H7 | |
| P478 | volume | 7 |
| Q61810394 | Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis | cites work | P2860 |
Search more.